Marker of Preclinical Alzheimer's Disease Associated With Loneliness

by Julia Samuel on  November 2, 2016 at 10:26 PM Research News
RSS Email Print This Page Comment
Cortical amyloid levels in the brain, a marker of preclinical Alzheimer disease, was tested for its associated with self-reported loneliness in a new article published online by JAMA Psychiatry.
Marker of Preclinical Alzheimer's Disease Associated With Loneliness
Marker of Preclinical Alzheimer's Disease Associated With Loneliness

Alzheimer disease (AD) is a process that moves through preclinical, mild cognitive impairment and dementia stages before it leads to progressive neuropsychiatric, cognitive and functional declines.

Nancy J. Donovan, M.D., of Brigham and Women's Hospital and Harvard Medical School, Boston, and coauthors used imaging as a measure of cortical amyloid levels in the brain and a loneliness scale to indicate levels of loneliness. The study included 43 women and 36 men with an average age of about 76.

Of the participants, 22 (28 percent) were carriers of the genetic risk factor apolipoprotein E4 (APOE4) and 25 (32 percent) were in the amyloid-positive group based on volume in imaging. The participants' average loneliness score was 5.3 on a scale of 3 to 12.

The authors report higher cortical amyloid levels were associated with greater loneliness after controlling for age, sex, APOE4, socioeconomic status, depression, anxiety and social network.

Participants in the amyloid-positive group were 7.5 times more likely to be classified as lonely then nonlonely compared with individuals in the amyloid-negative group. The association between high amyloid levels and loneliness also was stronger in APOE4 carriers than in noncarriers, according to the results.

Limitations of the study include the demographic profile of the participants who had high intelligence and educational attainment but limited racial and socioeconomic diversity. The participants also had better mental and physical health.

"We report a novel association of loneliness and cortical amyloid burden in cognitively normal adults and present evidence for loneliness as a neuropsychiatric symptom relevant to preclinical AD. This work will inform new research into the neurobiology of loneliness and other socioemotional changes in late life and may enhance early detection and intervention research in AD," the study concludes.

Source: Eurekalert

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Senior Citizens Get Tech Savvy 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.


Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive